-
Xoma: Q1 Earnings Snapshot
09 May 2024 13:06 GMT
… . (AP) — EMERYVILLE, Calif. (AP) — Xoma Corp. (XOMA) on Thursday reported a loss …
-
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
09 May 2024 11:30 GMT
… (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator … (Nasdaq: XOMAO). About XOMA Corporation
XOMA is a biotechnology royalty aggregator … will become commercially available.
XOMA CORPORATION
CONDENSED CONSOLIDATED BALANCE …
-
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
30 Apr 2024 11:30 GMT
… Sitko, Chief Investment Officer at XOMA. “XOMA structured an attractive, non- … formulations of sildenafil. About XOMA Corporation
XOMA is a biotechnology royalty … become commercially available.
XOMA Investor Contact
XOMA Media Contact
Juliane Snowden …
-
XOMA Earns $9M Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
25 Apr 2024 18:33 GMT
XOMA Corporation announced it has earned … is an important milestone for XOMA and our royalty portfolio, but … , Chief Executive Officer of XOMA.
In March 2021, XOMA paid $13.5 …
-
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
25 Apr 2024 11:30 GMT
… (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator … from Viracta Therapeutics. About XOMA Corporation
XOMA is a biotechnology royalty … become commercially available.
XOMA Investor Contact
XOMA Media Contact
Juliane Snowden …
-
FDA Action Alert: ImmunityBio, Aquestive, XOMA and More
22 Apr 2024 11:23 GMT
… Application (NDA).
Day One Positions XOMA-Partnered Tovorafenib as Monotherapy for … hair color, fatigue and rashes.
XOMA and Day One entered into …
-
XOMA Corporation Announces Closing of Tender Offer
03 Apr 2024 13:00 GMT
… 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a … advisor to Kinnate. About XOMA Corporation
XOMA is a biotechnology royalty aggregator … pharmaceutical or biotechnology companies. When XOMA acquires the future economics, …
-
XOMA Declares Quarterly Preferred Stock Dividends
21 Mar 2024 11:30 GMT
… 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today … April 3, 2024. About XOMA Corporation
XOMA is a biotechnology royalty aggregator … pharmaceutical or biotechnology companies. When XOMA acquires the future economics, …
-
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
19 Mar 2024 20:05 GMT
… February 16, 2024, XOMA Corporation (“XOMA” or the “Company”; … April 2024. About XOMA Corporation
XOMA is a biotechnology … biotechnology companies. When XOMA acquires the future economics … 658-9400.
XOMA Investor Contact
XOMA Media Contact
Juliane Snowden …
-
XOMA Stock Earnings: XOMA Misses EPS, Misses Revenue for Q4 2023
08 Mar 2024 18:46 GMT
Source: iQoncept / Shutterstock
XOMA (NASDAQ:XOMA) just reported results for the … fourth quarter of 2023.
XOMA reported earnings per share of … ;2024/03/xoma-stock-earnings-xoma-for-q4-of-2023 …